Is There a Better Option Than Hims for GLP-1 Therapy in 2026?
Hims has become synonymous with accessible telehealth. Their GLP-1 weight loss program brought compounded semaglutide and tirzepatide to a massive audience, and the operational execution is impressive. The app works. The medication ships. The billing is straightforward.
But operational excellence is not the same as clinical excellence. And for a growing number of patients, the question is not whether Hims delivers medication reliably, but whether it delivers the quality of medical care they actually need.
We compared Hims against the top GLP-1 programs in 2026 to find out where patients can genuinely do better.
Why People Ask If There Is Something Better Than Hims
The search for something better usually starts with a specific unmet need:
- Provider interactions feel like a formality. When your consultation is five minutes and the physician does not remember your case, you start wondering whether you are really being managed or just being prescribed.
- Standard protocols are not working. Hims follows a general titration schedule that works for most patients. But "most" is not "all," and patients who respond differently need a provider willing to deviate from the playbook.
- Side effects are not being addressed. Nausea, constipation, and other GLP-1 side effects are common. When your provider's response is to push through rather than adjust, patients rightfully look for better clinical care.
- Limited treatment scope. Weight management is increasingly understood as a multi-faceted challenge. Patients who want peptide therapies, combination protocols, or treatments that address inflammation and gut health alongside weight loss need a broader formulary.
- Progress has stalled. The first few months on a GLP-1 produce dramatic results for most patients. When the rate of progress slows, the quality of your clinical team becomes the difference between continued progress and a permanent plateau.
Programs That Offer a Better Experience Than Hims
1. Form Blends: Best for Patients Who Want a Real Physician Relationship
The biggest difference between Form Blends and Hims is the clinical model. At Form Blends, a licensed physician designs your protocol from the start, monitors your response over time, and makes adjustments based on how you are actually doing. This is not a conveyor belt. It is individualized medical care delivered through a telehealth platform.
The formulary is another major differentiator. Form Blends offers compounded semaglutide ($199/month), tirzepatide ($249/month), and peptide therapies including BPC-157. Patients who want a comprehensive approach to their health, not just a weight loss prescription, have options here that Hims simply does not provide.
Pricing is flat and transparent. No dose-based increases, no hidden consult fees, and no contracts. For patients on higher doses, Form Blends may actually be cheaper than Hims despite the higher base price.
Better than Hims for: Physician engagement, personalized protocols, peptide therapy, flat-rate pricing
Not as strong as Hims for: App polish, brand recognition, scale
2. Ro Body: Best for Patients Who Want Lab-Driven Care
Ro takes medical oversight seriously. Lab monitoring is a standard part of their GLP-1 program, which means dosing decisions are informed by blood work, not just patient self-reports. Their in-house pharmacy adds a layer of quality assurance that independent compounding partnerships cannot always match.
For patients who felt that Hims' clinical model was too superficial, Ro offers a meaningfully more rigorous approach. The tradeoff is that costs increase at higher doses and state availability is limited.
Better than Hims for: Lab-based monitoring, clinical rigor, pharmacy quality control
Not as strong as Hims for: Starting price consistency, nationwide availability
3. Calibrate: Best for Patients Who Want a Comprehensive Health Program
Calibrate does not just prescribe medication. Their program integrates GLP-1 therapy with nutrition coaching, exercise programming, sleep optimization, and behavioral health support. For patients who believe that medication alone will not produce lasting results, Calibrate offers the most comprehensive approach on the market.
The cost reflects that breadth. Calibrate is more expensive than Hims, and the commitment is longer. But for patients who have tried medication-only approaches and found them insufficient, the added structure can make the difference.
Better than Hims for: Lifestyle integration, behavioral support, long-term habit change
Not as strong as Hims for: Affordability, flexibility, simplicity
4. MEDVi: Best for Patients Who Want a Focused Weight Loss Platform
Where Hims is a general telehealth platform that happens to offer GLP-1 therapy, MEDVi is built specifically around weight management. That focus translates to a slightly more attentive clinical experience for weight loss patients. Pricing is competitive, and the enrollment process is straightforward.
Better than Hims for: Weight loss focus, dedicated program design
Not as strong as Hims for: Platform maturity, operational reliability, scale
5. WeightWatchers Clinic: Best for Patients Who Want Community Support
WeightWatchers Clinic combines GLP-1 prescribing with the support community that WeightWatchers is known for. For patients who thrive with group accountability and structured programs, this combination addresses the isolation that medication-only approaches can create.
Better than Hims for: Community support, structured programming, accountability
Not as strong as Hims for: Clinical depth, medication variety, cost
Comparison Table
| Program | Monthly Cost | Clinical Model | Medications | Peptides | Best For |
|---|---|---|---|---|---|
| Form Blends | $199+ | Physician-led, personalized | GLP-1s + peptides | Yes | Individualized care |
| Ro Body | $149+ | Lab-driven, evidence-based | GLP-1s | No | Clinical rigor |
| Calibrate | $150+ | Comprehensive metabolic | GLP-1s | No | Lifestyle integration |
| MEDVi | $149+ | Weight loss focused | GLP-1s | No | Dedicated weight loss |
| WW Clinic | Varies | Community-supported | GLP-1s | No | Group accountability |
Who Should Look for a Better Option Than Hims
Hims is perfectly adequate for a certain type of patient. But consider upgrading if:
- You need more than a prescription. If your current clinical experience amounts to a quick approval and a recurring shipment, you are not getting medical management. You are getting a subscription. Programs like Form Blends and Ro provide the kind of ongoing physician involvement that produces better, safer outcomes.
- Your weight loss has stalled. Plateaus require clinical intervention, not patience. If your Hims provider is not actively adjusting your protocol, a physician-led program may restart your progress.
- You want peptide therapy. Hims does not offer BPC-157 or other therapeutic peptides. If your health goals extend beyond weight loss, you need a provider with a broader formulary.
- Side effects are affecting your quality of life. GLP-1 side effects should be managed, not tolerated. A more engaged physician can adjust your dose, timing, or medication to reduce side effects while maintaining efficacy.
- You are paying more than you expected. If dose-dependent pricing has pushed your costs higher than anticipated, flat-rate alternatives may be both better and cheaper.
Frequently Asked Questions
Is Hims bad for GLP-1 therapy?
No. Hims is a legitimate, well-run platform that works for many patients. The question is whether it provides the level of care you specifically need. For patients who need minimal clinical interaction and prioritize convenience, Hims is fine. For patients who need personalized medical management, other programs are stronger.
What is the main weakness of Hims' GLP-1 program?
The high-volume clinical model. Hims processes a large number of patients, which means provider interactions tend to be brief and standardized. Patients who need individualized attention or complex dosing adjustments may find the experience insufficient.
Can I get peptide therapy through Hims?
No. As of 2026, Hims does not offer peptide therapies like BPC-157. Patients interested in peptides need to work with a provider that has a broader formulary, such as Form Blends.
Will switching from Hims to another program disrupt my treatment?
Not if you plan the transition properly. Enroll with your new provider and confirm your prescription before canceling Hims. Most patients can switch without any gap in medication.
The Bottom Line
Hims built a good platform for delivering GLP-1 medications at scale. But "good enough" is not the same as "best for you." If you want deeper clinical care, access to peptide therapies, or pricing that does not increase with your dose, the 2026 market has options that outperform Hims in the areas that matter most to your health.
Want a physician who actually manages your care? Form Blends pairs you with a licensed physician for personalized GLP-1 and peptide therapy. No volume-driven shortcuts, no contracts, no dose-based price increases.